share_log

騰盛博藥-B:(1) 建議採納經審核合併財務報表;(2) 建議重選退任董事;(3) 建議續聘核數師;(4) 建議發行及購回股份之一般授權;(5) 建議採納經修訂及重列組織章程大綱及細則;及(6) 股東週年大會通告

BRII-B: (1) PROPOSALS FOR ADOPTION OF THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) RE-APPOINTMENT OF AUDITOR; (4) GENERAL MANDATES TO ISSUE AND BUY-BACK SHARES; (5) PROPOSED ADOPTION OF THE AMENDED AND RESTATED

香港交易所 ·  Apr 27, 2023 05:51
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more